These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7700963)

  • 1. Structural and electronic conditions for anticonvulsant activity of bicyclic hydantoin derivatives.
    Karolak-Wojciechowska J; Kwiatkowski W; Kiec-Kononowicz K
    Pharmazie; 1995 Feb; 50(2):114-7. PubMed ID: 7700963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of CpFe(CO)(L) complexes of hydantoin anions (Cp = eta5-C5H5, L = CO, PPh3), and the use of the 5,5-diphenylhydantoin anion complexes as tracers in the nonisotopic immunoassay CMIA of this antiepileptic drug.
    Vessières A; Kowalski K; Zakrzewski J; Stepien A; Grabowski M; Jaouen G
    Bioconjug Chem; 1999; 10(3):379-85. PubMed ID: 10346867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bicyclic hydantoins with a bridgehead nitrogen. Comparison of anticonvulsant activities with binding to the neuronal voltage-dependent sodium channel.
    Brouillette WJ; Jestkov VP; Brown ML; Akhtar MS; DeLorey TM; Brown GB
    J Med Chem; 1994 Sep; 37(20):3289-93. PubMed ID: 7932556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of new antiepileptics. II. Anticonvulsant effect of hydantoin derivatives].
    Waser PG; Ganz AJ; Pfirrmann RW
    Arzneimittelforschung; 1977; 27(11):2125-8. PubMed ID: 580013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of substitution on anticonvulsant activity of some 5,5-diphenylhydantoin derivatives.
    Lange J; Lapszewicz J
    Acta Pol Pharm; 1990; 47(1-2):31-4. PubMed ID: 12959256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of quantitative structure-activity relationships and classification models for anticonvulsant activity of hydantoin analogues.
    Sutherland JJ; Weaver DF
    J Chem Inf Comput Sci; 2003; 43(3):1028-36. PubMed ID: 12767162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural modifications of the primary amino group of anticonvulsant aryl semicarbazones.
    Dimmock JR; Puthucode RN; Lo MS; Quail JW; Yang J; Stables JP
    Pharmazie; 1996 Feb; 51(2):83-8. PubMed ID: 8720804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of molecular electrostatic potentials for analysis of anticonvulsant activities of phenylsuccinimides.
    Kwiatkowski W; Karolak-Wojciechowska J
    SAR QSAR Environ Res; 1993; 1(2-3):233-44. PubMed ID: 8790636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.
    Jansen M; Potschka H; Brandt C; Löscher W; Dannhardt G
    J Med Chem; 2003 Jan; 46(1):64-73. PubMed ID: 12502360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and electronic structures of two (anticonvulsant) diphenylhydantoin derivatives.
    Ciechanowicz-Rutkowska M; Kieć-Kononowicz K; Howard ST; Lieberman B; Hursthouse MB
    Acta Crystallogr B; 1994 Feb; 50 ( Pt 1)():86-96. PubMed ID: 8148098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsants. 5. Derivatives of 5-ethyl-5-phenylhydantoin and 5,5-diphenylhydantoin.
    Vida JA; O'Dea MH; Samour CM; Reinhard JF
    J Med Chem; 1975 Apr; 18(4):383-5. PubMed ID: 1121005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of 6-amino-1,4-oxazepane-3,5-dione derivatives as novel broad spectrum anticonvulsants.
    Sharma G; Park JY; Park MS
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3188-91. PubMed ID: 18479918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant activity of phenylmethylenehydantoins: a structure-activity relationship study.
    Thenmozhiyal JC; Wong PT; Chui WK
    J Med Chem; 2004 Mar; 47(6):1527-35. PubMed ID: 14998338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins.
    Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X
    Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and X-ray crystal structure study of the hydroxyurea and hydantoin derivatives of L-valine.
    Opacić N; Zorc B; Cetina M; Mrvos-Sermek D; Raić-Malić S; Mintas M
    J Pept Res; 2005 Aug; 66(2):85-93. PubMed ID: 16000122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticonvulsant activity of some N-phenyl-2-phtalimidoethanesulfonamide derivatives.
    Akgul O; Sultan Kilic F; Erol K; Pabuccuoglu V
    Arch Pharm (Weinheim); 2007 Dec; 340(12):656-60. PubMed ID: 18038376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant activity of reaction products of 5,5-diphenylhydantoin with substituted methylene bromides.
    Usifoh CO
    Arch Pharm (Weinheim); 2001 Nov; 334(11):366-8. PubMed ID: 11822175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity study on anticonvulsant (thio) hydantoins using molecular connectivity indices.
    Dang P; Madan AK
    J Chem Inf Comput Sci; 1994; 34(5):1162-6. PubMed ID: 7962214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A search for new anticonvulsant compounds among 3-aryl-5-benzylidene derivatives of 2-thiohydantoin.
    Korohoda MJ; Kleinrok Z; Przegaliński E
    Pol J Pharmacol Pharm; 1976; 28(4):329-33. PubMed ID: 981022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant activity of some xanthone derivatives.
    Marona H; Pekala E; Antkiewicz-Michaluk L; Walczak M; Szneler E
    Bioorg Med Chem; 2008 Aug; 16(15):7234-44. PubMed ID: 18640843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.